Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus
Florine Kastelein, Katharina Biermann, Ewout W Steyerberg, Joanne Verheij, Marit Kalisvaart, Leendert H J Looijenga, Hans A Stoop, Laurens Walter, Ernst J Kuipers, Manon C W Spaander, Marco J Bruno, on behalf of the ProBar-study group
Gut Dec 2013, 62 (12) 1676-1683; DOI: 10.1136/gutjnl-2012-303594